Kyorin Pharmaceutical Co (TSE:4569) YoY Rev. per Sh. Growth : -1.50% (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kyorin Pharmaceutical Co YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Kyorin Pharmaceutical Co's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was -1.50%.

Kyorin Pharmaceutical Co's Revenue per Share for the three months ended in Sep. 2024 was 円465.11.

Kyorin Pharmaceutical Co YoY Rev. per Sh. Growth Historical Data

The historical data trend for Kyorin Pharmaceutical Co's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyorin Pharmaceutical Co YoY Rev. per Sh. Growth Chart

Kyorin Pharmaceutical Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-6.45

2.55

7.33

5.37

8.72

Kyorin Pharmaceutical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Mar25
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															2.01	-1.17	1.87	-1.50	-100.00

Kyorin Pharmaceutical Co YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Kyorin Pharmaceutical Co's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2025 is calculated as:

	YoY Rev. per Sh. Growth (A: Mar. 2025 )
=	(Revenue per Share (A: Mar. 2025 )	-	Revenue per Share (A: Mar. 2024 ))	/	\| Revenue per Share (A: Mar. 2024 ) \|
=	(2264.549	-	2082.838)	/	\| 2082.838 \|
=	8.72 %

Kyorin Pharmaceutical Co's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=	(Revenue per Share (Q: Sep. 2024 )	-	Revenue per Share (Q: Sep. 2023 ))	/	\| Revenue per Share (Q: Sep. 2023 )) \|
=	(465.108	-	472.191)	/	\| 472.191 \|
=	-1.50 %

Kyorin Pharmaceutical Co YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Kyorin Pharmaceutical Co's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyorin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (TSE:4569) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311

Website

https://www.kyorin-pharm.co.jp

Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Kyorin Pharmaceutical Co Headlines

No Headlines